VIDEO: Anti-TNF use by pregnant women with IBD increases preeclampsia risk

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Sunanda V. Kane, MD, a gastroenterologist and professor of medicine at Mayo Clinic in Rochester, Minnesota, discusses the results of a study that demonstrated that pregnant women with inflammatory bowel disease receiving anti-TNF therapy are at an increased risk for preeclampsia.“We know that women with inflammatory bowel disease when they are pregnant are at increased risk for adverse pregnancy outcomes,” Kane told Healio Gastroenterology and Liver Disease. “PreeclampsiaRead More

Share on facebook
Share on twitter
Share on linkedin